Brian S. Roberts

Array ( [id] => 7199526 [patent_doc_number] => 20040086518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Universal vaccine and method for treating cancer employing telomerase reverse transcriptase' [patent_app_type] => new [patent_app_number] => 09/788110 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10028 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086518.pdf [firstpage_image] =>[orig_patent_app_number] => 09788110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095661 [patent_doc_number] => 20020051977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Compositions and methods for the therapy and diagnosis of prostate cancer' [patent_app_type] => new [patent_app_number] => 09/780669 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 73318 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051977.pdf [firstpage_image] =>[orig_patent_app_number] => 09780669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064373 [patent_doc_number] => 20020032314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Synthetic peptide neutrophil cell chemotactic agents' [patent_app_type] => new [patent_app_number] => 09/777328 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4706 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032314.pdf [firstpage_image] =>[orig_patent_app_number] => 09777328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6224508 [patent_doc_number] => 20020004232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Tumor suppressor gene del-27' [patent_app_type] => new [patent_app_number] => 09/771404 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3380 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004232.pdf [firstpage_image] =>[orig_patent_app_number] => 09771404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814236 [patent_doc_number] => 20020039573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Compounds and methods for prevention and treatment of HER-2/neu associated malignancies' [patent_app_type] => new [patent_app_number] => 09/765973 [patent_app_country] => US [patent_app_date] => 2001-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12004 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20020039573.pdf [firstpage_image] =>[orig_patent_app_number] => 09765973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1108323 [patent_doc_number] => 06809189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-26 [patent_title] => 'Apoptin-associating protein' [patent_app_type] => B2 [patent_app_number] => 09/764176 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15904 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809189.pdf [firstpage_image] =>[orig_patent_app_number] => 09764176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774638 [patent_doc_number] => 20030017976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Therapeutic properties of liposome-encapsulated immunomodulators' [patent_app_type] => new [patent_app_number] => 09/764546 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23982 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017976.pdf [firstpage_image] =>[orig_patent_app_number] => 09764546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801417 [patent_doc_number] => 20020009726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'CD40 associated proteins' [patent_app_type] => new [patent_app_number] => 09/757041 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16939 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009726.pdf [firstpage_image] =>[orig_patent_app_number] => 09757041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6896134 [patent_doc_number] => 20010026924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Noninvasive detection of colorectal cancer and other gastrointestinal pathology' [patent_app_type] => new [patent_app_number] => 09/755233 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4509 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20010026924.pdf [firstpage_image] =>[orig_patent_app_number] => 09755233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290668 [patent_doc_number] => 06630314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-07 [patent_title] => 'Noninvasive detection of colorectal cancer and other gastrointestinal pathology' [patent_app_type] => B2 [patent_app_number] => 09/755232 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4467 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630314.pdf [firstpage_image] =>[orig_patent_app_number] => 09755232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142444 [patent_doc_number] => 20020002271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Antibody purification' [patent_app_type] => new [patent_app_number] => 09/754998 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12874 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002271.pdf [firstpage_image] =>[orig_patent_app_number] => 09754998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6308159 [patent_doc_number] => 20020095025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Isolation and uses of caveolae' [patent_app_type] => new [patent_app_number] => 09/734490 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14969 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20020095025.pdf [firstpage_image] =>[orig_patent_app_number] => 09734490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634571 [patent_doc_number] => 06657048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-02 [patent_title] => 'Individualized anti-cancer antibodies' [patent_app_type] => B2 [patent_app_number] => 09/727361 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10345 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/657/06657048.pdf [firstpage_image] =>[orig_patent_app_number] => 09727361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308344 [patent_doc_number] => 06617429 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof' [patent_app_type] => B1 [patent_app_number] => 09/705872 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12215 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617429.pdf [firstpage_image] =>[orig_patent_app_number] => 09705872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236390 [patent_doc_number] => 06689867 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Placenta derived apoptotic factor' [patent_app_type] => B1 [patent_app_number] => 09/684327 [patent_app_country] => US [patent_app_date] => 2000-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 6085 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689867.pdf [firstpage_image] =>[orig_patent_app_number] => 09684327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856924 [patent_doc_number] => 07375183 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-20 [patent_title] => 'Mesothelin, immunogenic peptides derived therefrom, and compositions comprising mesothelin, or immunogenic peptides thereof' [patent_app_type] => utility [patent_app_number] => 09/684599 [patent_app_country] => US [patent_app_date] => 2000-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18335 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375183.pdf [firstpage_image] =>[orig_patent_app_number] => 09684599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326381 [patent_doc_number] => 06602978 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Synthetic peptide neutrophil cell chemotactic agents' [patent_app_type] => B1 [patent_app_number] => 09/644038 [patent_app_country] => US [patent_app_date] => 2000-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 4954 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602978.pdf [firstpage_image] =>[orig_patent_app_number] => 09644038 [rel_patent_id] =>[rel_patent_doc_number] =>)